dihydroxyphenylalanine has been researched along with Bladder Disorder, Neurogenic in 5 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schneider, E | 1 |
| Patras, L | 1 |
| Fischer, PA | 1 |
| Uono, M | 1 |
| Mahoudeau, D | 1 |
| Singer, B | 1 |
| Gilbert, JC | 1 |
| Goulon, M | 1 |
| Gajdos, P | 1 |
| Aminoff, MJ | 1 |
| Wilcox, CS | 1 |
| Woakes, MM | 1 |
| Kremer, M | 1 |
| Sharpe, J | 1 |
| Marquez-Julio, A | 1 |
| Ashby, P | 1 |
1 review available for dihydroxyphenylalanine and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
[Clinical studies of autonomic centers].
Topics: Autonomic Nervous System; Dihydroxyphenylalanine; Epilepsy, Temporal Lobe; Fecal Incontinence; Human | 1972 |
4 other studies available for dihydroxyphenylalanine and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
[Neurogenic bladder disturbances in Parkinson's disease (author's transl)].
Topics: Adult; Age Factors; Aged; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disea | 1978 |
[Shy-Drager disease. Hemodynamic and pharmacodynamic studies. Value of cyproheptadine].
Topics: Cyproheptadine; Dihydroxyphenylalanine; Fecal Incontinence; Female; Humans; Hypotension, Orthostatic | 1972 |
Levodopa therapy for Parkinsonism in the Shy-Drager syndrome.
Topics: Blood Pressure; Dihydroxyphenylalanine; Evaluation Studies as Topic; Fecal Incontinence; Female; Hum | 1973 |
Idiopathic orthostatic hypotension treated with levodopa and MAO inhibitor: a preliminary report.
Topics: Basal Ganglia Diseases; Brain Stem; Catecholamines; Dihydroxyphenylalanine; Drug Synergism; Fecal In | 1972 |